Animal Models for the Research of Alzheimer's Disease and Neurodegeneration
A special issue of Geriatrics (ISSN 2308-3417).
Deadline for manuscript submissions: closed (16 August 2023) | Viewed by 220
Special Issue Editors
Interests: phospholipids; Alzheimer's disease; mouse models; apolipoprotein; endo-lysosomal pathways; drug development
Special Issues, Collections and Topics in MDPI journals
Interests: Alzheimer's disease; memory; mouse models; human-induced pluripotent stem cells; phospholipids; kinase signaling; molecular pharmacology; tauopathy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Alzheimer’s disease (AD) is a major healthcare burden with a large patient population. Currently there are no effective therapies to stop or slow down the progression of AD. The major challenge in this field is the lack of a better understanding of AD pathophysiology due to its multifaceted disease mechanisms. Animal models have been widely utilized in AD research to study the pathogenesis of AD and test drug efficacy at pre-clinical stages. In the past decade or so, innovative approaches have been developed including novel animal modeling technologies to better recapitulate pathological changes in AD and neurodegeneration in vivo, and to guide the preclinical development of efficacious therapies for AD.
This Special Issue will examine the currently available mouse models of AD, including both familial and sporadic AD mouse models, as well as other animal models. The development of animal models of AD-related neurodegenerative disorders will be explored as well. The pathological and behavioral phenotypes of various animal models of AD and neurodegenerative disorders will be discussed. The approaches of modeling environmental and genetic risk factors of AD in vivo in animals, as well as the selection of animal modeling for preclinical drug development in AD, will be investigated.
You may choose our Joint Special Issue in Cells.
Dr. Dongming Cai
Dr. Mariana Lemos Duarte
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Geriatrics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer's disease (AD)
- animal models
- disease mechanisms
- pathological changes
- behavioral phenotypes
- environmental factors
- genetic risk factors
- drug development
